½ÃÀ庸°í¼­
»óǰÄÚµå
1552614

¼¼°èÀÇ ³ª³ëĸ½¶ ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¿ëµµº°, Ä¡·á ºÐ¾ßº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)

Nanocapsules Market Size, Share & Trends Analysis Report By Application (Healthcare, Food & Nutraceuticals, Cosmetics), By Therapeutic Area (Oncology, Pain Management, Endocrinology), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³ª³ëĸ½¶ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è ³ª³ëĸ½¶ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 48¾ï 9,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2024³âºÎÅÍ 2030³â±îÁöÀÇ CAGRÀº 5.4%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ª³ëĸ½¶Àº Ç¥Àû Àü´Þ¿¡ ÀÇÇØ »ý¹°È°¼ººÐÀÚ¸¦ Àü´ÞÇϸç, ÇコÄɾî, À¯ÀüÀÚ°øÇÐ, ½Äǰ°úÇаú ³ó¾÷, È­Àåǰ, ³ó¾à, Ŭ·»Â¡ Á¦Ç° µî ´Ù¾çÇÑ »ê¾÷¿¡¼­ ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ »ê¾÷¿¡¼­ ÀÌ·¯ÇÑ Á¦Ç°ÀÌ ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®¿¡ ½Å±ÔÇÏ°í °³¼±µÈ Ä¡·á¹ý°ú ¼Ö·ç¼ÇÀÇ °³¹ß ¹× »ó¾÷È­¿¡ À¯¸®ÇÑ ±âȸ°¡ ¾à¼ÓµÇ°í ÀÖ½À´Ï´Ù.

³ª³ëĸ½¶ÀÇ »ý¸í°úÇÐ ¿ëµµ´Â ³ª³ë»çÀÌÁî ¾à¹° ¿î¹Ýü¸¦ Ç¥Àû ±¸¿ªÀ¸·Î Á¦¾îÇÏ´Â È¿°úÀûÀÎ ¹æÃâÀ» ´Þ¼ºÇÏ´Â ´É·Â¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. ÀÇ·á ºÐ¾ßÀÇ ³ª³ëĸ½¶Àº È¿À²ÀûÀÎ ¾à¹° Ÿ°ÙÆÃÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ³ª³ëĸ½¶Àº ºÐ»ê ¾ÈÁ¤¼º°ú ½Å¼ÓÇÑ »ý¸®ÇÐÀû ¹ÝÀÀÀ» Á¦°øÇϸç, ¹ßÈ­¼º°ú »êÈ­ Ư¼ºÀº ÀÇ·á Àå¾Ö¸¦ Áø´ÜÇϰí Ä¡·áÇϱâ À§ÇÑ È¿°úÀûÀÎ ¾àÁ¦·Î ¼ö¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á¿¡¼­ÀÇ ³ª³ë±â¼úÀÇ ÀÀ¿ëÀº ƯÈ÷ Á¾¾çÇп¡¼­ Áß¿äÇÑ Ä¡·áÀû ÀÌÁ¡À» Æ÷ÇÔÇÏ´Â °ÍÀ¸·Î ¹àÇôÁ³À¸¸ç, ±× °á°ú ³ª³ëĸ½¶ÀÇ È­Çпä¹ý ¶Ç´Â Áø´Ü Ư¼ºÀ» Æ÷ÇÔÇÏ´Â »õ·Î¿î ºÐ¾ßÀÎ ³ª³ëÁ¾¾çÇÐÀÌ ÃâÇö Çß½À´Ï´Ù.

³ª³ë±â¼úÀÇ ÀÌ¿ëÀº °úÇÐÀÇ ´Ù¾çÇÑ È帧¿¡ ÆÛÁö°í ÀÖÀ¸¸ç, È­Àåǰ ¹× ³ó¾÷ ºÐ¾ß¿¡µµ ÀÀ¿ëµÇ°í ÀÖ½À´Ï´Ù. È­ÀåǰÀº È¿À²ÀûÀÎ ±¹¼Ò Åõ¿©¸¦ À§ÇØ °íºÐÀÚ ³ª³ëÀÔÀÚ(³ª³ë½ºÇÇ¾î ¹× ³ª³ëĸ½¶)¸¦ ÀÌ¿ëÇÕ´Ï´Ù. ÇÑÆí, ³ª³ë±â¼úÀº Çö´ë³ó¾÷¿¡¼­ °¡Àå Áß¿äÇÑ µµ±¸ Áß Çϳª·Î Àνĵǰí ÀÖÀ¸¸ç, °¡±î¿î ¹Ì·¡¿¡ °­·ÂÇÑ °æÁ¦ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ª³ë±â¼úÀº ¼ö¸¹Àº ÀáÀçÀû ÀÌÁ¡À» °¡Áö°í ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, ÇöÀç ½Ã³ª¸®¿À¿¡¼­´Â ³ó¾÷¿¡ÀÇ ÀÀ¿ëÀÌ ºÎÁ·Çϰí, Å« ½ÃÀå °¡´É¼ºÀ» ´Þ¼ºÇϱ⿡´Â À̸£Áö ¸øÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÃÖ±Ù ¿¬±¸¿¡¼­´Â ³ª³ëĸ½¶°ú °¢ Á¦Ç°¿¡ ´ëÇÑ È£ÀÇÀûÀÎ ¼±È£µµ°¡ ÀÔÁõµÇ¾úÀ¸¸ç, ¸íÈ®ÇÑ ÀÌÁ¡À» °¡Áø ³ª³ëÅ×Å© Á¦Ç°ÀÇ »ó¾÷È­°¡ ÁøÇàµÊ¿¡ µû¶ó º¸´Ù ¼¶¼¼ÇÑ ÀÀ¿ë¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼ö¿ëÀÌ ÃËÁøµÉ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

³ª³ëĸ½¶ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¾¾çÇÐ ºÐ¾ßÀÇ ³ª³ëĸ½¶Àº Á¾¾ç ºÎÀ§¸¦ Ÿ°ÙÀ¸·Î ÇÏ¿© ¼³°èµÈ ÈÄ, »óÅÂÀÇ º¯È­¿¡ µû¶ó ³»¿ë¹°ÀÌ ¹èÃâµË´Ï´Ù.
  • ³ª³ëĸ½¶ÀÇ ¾à¹° Àü´Þ°ú °ü·ÃÇÏ¿© ÅëÁõ °ü¸® ¹× ³»ºÐºñÇÐ ºÐ¾ß¿¡¼­ ±Þ¼ÓÇÑ °³¹ßÀÌ ÁøÇàµÇ°í ÀÖÀ¸¸ç, »ó¾÷È­ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.
  • ÇコÄɾî´Â ½ÃÀåÀ» µ¶Á¡Çϰí, 2023³â¿¡´Â 63.3%ÀÇ Á¡À¯À²À» Â÷ÁöÇϸç, ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì ±¹°¡¿Í À¯·´ ±¹°¡´Â ÃÑ 60% ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. ÀÌ´Â ³ª³ëĸ½¶ÀÇ »ç¿ëÀ» Æ÷ÇÔÇÏ¿© ½Å±ÔÇÏ°í ¸Å¿ì È¿°úÀûÀÎ °³¼±µÈ Ä¡·á¹ýÀÇ °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃá ¿¬±¸°³¹ß ¹× ÅõÀÚ È°µ¿À» Áõ°¡½ÃŰ´Â ¼±Áø±¹ÀÇ ±â¿© ¶§¹®ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ³ª³ëĸ½¶ ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå ¼Ò°³/°èÅë Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ³ª³ëĸ½¶ ½ÃÀå ºÐ¼® Åø
    • Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ³ª³ëĸ½¶ ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ³ª³ëĸ½¶ ½ÃÀå : ¿ëµµº¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
  • ÇコÄɾî
  • ½Äǰ ¹× ¿µ¾ç º¸Á¶ ½Äǰ
  • È­Àåǰ
  • ±âŸ

Á¦5Àå ³ª³ëĸ½¶ ½ÃÀå : Ä¡·á ºÐ¾ßº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ³ª³ëĸ½¶ ½ÃÀå : Ä¡·á ºÐ¾ß º¯µ¿ ºÐ¼®, 2023³â ¹× 2030³â
  • Á¾¾çÇÐ
  • ÅëÁõ °ü¸®
  • ³»ºÐºñÇÐ
  • ±âŸ

Á¦6Àå ³ª³ëĸ½¶ ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ³ª³ëĸ½¶ ½ÃÀå Á¡À¯À², Áö¿ªº°, 2023³â ¹× 2030³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷ ºÐ·ù
  • ±â¾÷ È÷Æ®¸Ê ºÐ¼®
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • BioDelivery Sciences
    • Camurus
    • Carlina Technologies
    • Cerulean Pharma Inc.
    • Nano Green Sciences, Inc.
    • NanoNutra
    • NanoSphere Health Science
    • Eos Biosciences, Inc.
    • PolyMicrospheres
    • GAT Food Essentials
JHS 24.09.24

Nanocapsules Market Growth & Trends:

The global nanocapsules market size is expected to reach a value of USD 4.89 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.4% from 2024 to 2030. Nanocapsules deliver bioactive molecules by targeted delivery and find application in various industries such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. The wide usage of these products across several industries promises lucrative opportunities for the development and commercialization of novel and improved therapies and solutions.

Nanocapsules' life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. Nanocapsules in the field of healthcare is gaining popularity for its efficient drug targeting. It offers dispersion stability and the quick physiological response and the pyrophoric and oxidation properties are responsible for increased acceptance as an effective agent to diagnose and cure medical disorders. The application of nanotechnology in medicine has been realized to contain important therapeutic benefits, especially in oncology, resulting in the emergence of nano-oncology, a new field involving the chemotherapeutic or diagnostic properties of nanocapsules.

The use of nanotechnology has stretched across various streams of science and has found applications in the field of cosmetics and agriculture. Cosmetic products utilize polymeric nanoparticles (nanospheres and nanocapsules) for efficient topical administration. On the other hand, nanotechnology is recognized to be one of the most important tools in modern agriculture and is anticipated to become a driving factor for strong economic growth in the near future. However, despite the numerous potential advantages of nanotechnology, agricultural applications are scarce in the current scenario and yet to achieve significant market potential. However, recent studies have demonstrated a positive preference for nanocapsules and their respective products and the increasing commercialization of nanotech products with clear benefits will likely drive consumer acceptance of more sensitive applications.

Nanocapsules Market Report Highlights:

  • Nanocapsules in oncology are engineered to target tumor sites followed by discharge of contents upon a change in conditions.
  • Rapid development in the fields of pain management and endocrinology with respect to nanocapsule drug delivery is in pipeline and has a high probability of commercialization.
  • Healthcare dominated the market and accounted for a share of 63.3% in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • North America and Europe accounted for a collective market share of 60%. this is attributed to the contribution of highly developed countries in increasing R&D and investing activities focusing on the development of novel and highly effective improved therapies involving the use of nanocapsule.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nanocapsules Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Nanocapsules Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Nanocapsules Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nanocapsules Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Healthcare
    • 4.3.1. Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Food & Nutraceuticals
    • 4.4.1. Food & Nutraceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Cosmetics
    • 4.5.1. Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nanocapsules Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nanocapsules Market: Therapeutic Area Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain Management
    • 5.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nanocapsules Market: Regional Estimates & Trend Analysis

  • 6.1. Nanocapsules Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. BioDelivery Sciences
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Camurus
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Carlina Technologies
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Cerulean Pharma Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Nano Green Sciences, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. NanoNutra
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. NanoSphere Health Science
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Eos Biosciences, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. PolyMicrospheres
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. GAT Food Essentials
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦